Medication info
Alducal 60/2.5 mg

Alducal 60/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
S-Amlodipine Besylate Dihydrate›3.69mg / 1 tabletFimasartan Potassium Trihydrate›66.01mg / 1 tablet
Manufacturer / importer
Allico Pharmaceutical Co., Ltd.
Appearance
Yellow round-cornered square-shaped film-coated tablets
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Approval status
Active

MFDS item code 202204650 · Approved 2022.12.27 · Insurance code 656005410

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Allico Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is a medication primarily used when blood pressure is insufficiently controlled in patients with essential hypertension as monotherapy. This medication effectively lowers blood pressure, helping to prevent complications due to hypertension. It works by relaxing blood vessels, improving blood circulation, and reducing the load on the heart. Therefore, it plays an important role in hypertension management and enhances the overall cardiovascular health of patients. For these reasons, pimasartan potassium is actively used in hypertension treatment.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication can cause serious harm to the fetus and newborn when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Those with allergies to the components of this medication or similar classes of drugs, pregnant or breastfeeding individuals, those undergoing renal dialysis, individuals with severely impaired liver function, and those with biliary obstruction should not take this medication. Diabetic patients with moderate or greater renal impairment, those taking certain antihypertensive medications, individuals with lactose intolerance or genetic metabolic disorders, should also avoid this medication. Patients with severe aortic stenosis or in shock should avoid using this medication. Those with low blood volume or low body salt, impaired kidney function, renal artery hypertension, aortic or heart valve disorders, severe hypotension, the elderly, and individuals allergic to colorants in this medication should take special care when using it. Taking this medication may lead to side effects such as dizziness, headaches, facial swelling, urination problems, insomnia, and flushing; rarely, severe kidney issues or symptoms of low blood pressure may occur. If blood pressure drops too low, immediate consultation with healthcare professionals is essential, and caution should be exercised when driving or operating machinery as drowsiness or dizziness may occur. Furthermore, this medication may interact with other antihypertensive drugs, potassium-sparing diuretics, certain antibiotics, antifungals, and lithium preparations, so if you are taking other medications, it is imperative to inform your healthcare provider. Women who are pregnant or breastfeeding should avoid taking this medication, and if breastfeeding, they should consult with their healthcare provider about the use of this medication and breastfeeding cessation. For children under 18 years of age, the safety and efficacy of this medication have not been established, so it is advisable to avoid use. In case of overdose, low blood pressure, palpitations, and in severe cases, shock may occur, requiring immediate emergency treatment. Lastly, this medication should be kept out of reach of children, and it is safe not to transfer it to another container.

Side effects

Dizziness, positional dizziness, headache, facial swelling, peripheral edema, urination disorder, insomnia, flushing, syncope, sedation, migraine, dyspepsia, vomiting, nausea, abdominal pain, asthenia, foreign body sensation, elevated liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase, cough, muscle contraction, musculoskeletal stiffness, pruritus, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal canal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, cerebral infarction deterioration, cerebral hemorrhage, liver cancer, colon carcinoma, neoplasm of unknown origin, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, pulmonary fibrosis, pharyngitis, pneumonia, lung disease, death, exacerbation of low back pain, osteoarthritis, arthritis, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, hypertension, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, chest pain, back pain, edema, limb pain, fatigue, fever, neck/shoulder pain, fracture, myalgia, pharyngitis, upper respiratory infection, sputum, rhinitis, epistaxis, bronchitis, sensory disturbances, numbness, tremor, hypertonia, insomnia, depression, anxiety, memory impairment, loss of appetite, gastroesophageal reflux, gastritis, diarrhea, constipation, functional gastrointestinal disorder, dysuria, hyperlipidemia, dyslipidemia, frequent urination, urinary incontinence, kidney stones, exacerbation of chronic renal failure, herpes zoster, panic reaction, Alzheimer's disease, suicide attempt, restlessness, hyperthyroidism, hypothyroidism, increased TSH, tachycardia, arrhythmia, ventricular tachycardia, angina, myeloproliferative disease, exacerbation of anemia, iron deficiency anemia, tinnitus, hearing impairment, hearing loss, pelvic inflammatory disease, vaginitis, benign prostatic hyperplasia, scrotal pain, blood pressure fluctuations, fatty liver, localized inflammation, soft tissue inflammation, lymphadenopathy, postoperative pain, allergy, chills, nasal polyps, pulmonary tuberculosis, axillary pain, periorbital edema, allergic reaction, hypotension, vasculitis, tension increase, sensory decrease, peripheral neuropathy, taste disorder, tremor, extrapyramidal disorder, gynecomastia, changes in bowel habits, dry mouth, gingival hypertrophy, pancreatitis, hyperglycemia, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, increased frequency of urination, nocturia, hepatitis, jaundice, elevated liver enzyme levels, myocardial infarction, chest pain, sinus node block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, skin erythema, maculopapular rash, heaviness, warmth, impaired glucose tolerance, weakness, elevated serum potassium levels, increased serum lithium levels, hypotension, loss of consciousness, dyspnea, fluid requirement, vasoconstrictor requirement, delayed vascular tone and blood pressure recovery, reflex tachycardia, systemic hypotension, shock, palpitations, drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light; therefore, it should be stored in a tightly sealed container that blocks light. It is advisable to keep the storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage helps maintain the medication's efficacy and safety.

Appearance and packaging

Appearance

Yellow round-cornered square-shaped film-coated tablets

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.